A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Completed · Phase 4

Conditions studied: Obesity

In brief

The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.

Key facts

Study ID

NCT00234988

Run by

Abbott

People needed

93

Starts

2004-06-01

Last updated by the study team

2008-07-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has nutritional obesity and BMI >30 kg/m

You may not qualify if…

• Type 1 or type 2 diabetes mellitus
• Inadequately controlled hypertension
• History of Gilles de la Tourette's Syndrome.
• Use of any MAOIs, SSRIs, amino acids, antimigraine drugs, opioids
• Hypothyroidism or hyperthyroidism.
• History of:
• benign prostatic hyperplasia
• neurological disorders
• psychiatric illness
• severe renal or hepatic impairments
• narrow-angle glaucoma
• History of cardiovascular disease or cerebrovascular disease
• Persistent tachycardia at rest
• Pulmonary hypertension
• Phaeochromocytoma

Where it is running

• Global Medical Information - Abbott — North Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.